Rhumbline Advisers Jazz Pharmaceuticals PLC Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rhumbline Advisers holds 165,012 shares of JAZZ stock, worth $22.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
165,012
Previous 164,556 0.28%
Holding current value
$22.7 Million
Previous $20.4 Million 14.28%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$97.78 - $126.44 $44,587 - $57,656
456 Added 0.28%
165,012 $17.5 Million
Q1 2025

Apr 08, 2025
SELL
$120.07 - $144.17 $360,690 - $433,086
-3,004 Reduced 1.79%
164,556 $20.4 Million
Q4 2024

May 29, 2025
BUY
$107.32 - $127.74 $322,389 - $383,730
3,004 Added 1.83%
167,560 $20.6 Million
Q4 2024

Jan 30, 2025
BUY
$107.32 - $127.74 $188,346 - $224,183
1,755 Added 1.06%
167,560 $20.6 Million
Q3 2024

Nov 12, 2024
SELL
$100.57 - $116.37 $361,549 - $418,350
-3,595 Reduced 2.12%
165,805 $18.5 Million
Q2 2024

Aug 01, 2024
SELL
$103.94 - $118.98 $1.62 Million - $1.86 Million
-15,597 Reduced 8.43%
169,400 $18.1 Million
Q1 2024

May 09, 2024
SELL
$115.19 - $132.77 $90,193 - $103,958
-783 Reduced 0.42%
184,997 $22.3 Million
Q4 2023

Feb 08, 2024
SELL
$114.26 - $136.0 $252,400 - $300,424
-2,209 Reduced 1.18%
185,780 $22.9 Million
Q3 2023

Nov 09, 2023
SELL
$122.0 - $145.31 $204,472 - $243,539
-1,676 Reduced 0.88%
187,989 $24.3 Million
Q2 2023

Aug 08, 2023
BUY
$122.5 - $147.16 $880,775 - $1.06 Million
7,190 Added 3.94%
189,665 $23.5 Million
Q1 2023

May 11, 2023
BUY
$133.98 - $160.47 $194,003 - $232,360
1,448 Added 0.8%
182,475 $26.7 Million
Q4 2022

Feb 14, 2023
BUY
$129.72 - $159.85 $47,996 - $59,144
370 Added 0.2%
181,027 $28.8 Million
Q3 2022

Nov 10, 2022
BUY
$126.59 - $161.18 $507,119 - $645,687
4,006 Added 2.27%
180,657 $24.1 Million
Q2 2022

Aug 11, 2022
BUY
$141.59 - $168.66 $2.05 Million - $2.44 Million
14,465 Added 8.92%
176,651 $27.6 Million
Q1 2022

May 12, 2022
SELL
$129.64 - $160.7 $94,507 - $117,150
-729 Reduced 0.45%
162,186 $25.2 Million
Q4 2021

Feb 10, 2022
BUY
$119.87 - $145.67 $1.15 Million - $1.4 Million
9,591 Added 6.26%
162,915 $20.8 Million
Q3 2021

Nov 12, 2021
SELL
$128.64 - $184.79 $527,552 - $757,823
-4,101 Reduced 2.61%
153,324 $20 Million
Q2 2021

Aug 05, 2021
BUY
$160.2 - $186.42 $1.22 Million - $1.41 Million
7,590 Added 5.07%
157,425 $28 Million
Q1 2021

May 06, 2021
SELL
$150.19 - $173.5 $129,163 - $149,210
-860 Reduced 0.57%
149,835 $24.6 Million
Q4 2020

Feb 10, 2021
SELL
$140.71 - $165.05 $1.4 Million - $1.65 Million
-9,970 Reduced 6.21%
150,695 $24.9 Million
Q3 2020

Nov 12, 2020
BUY
$105.46 - $144.13 $9.01 Million - $12.3 Million
85,444 Added 113.59%
160,665 $22.9 Million
Q2 2020

Aug 13, 2020
BUY
$95.68 - $121.88 $245,227 - $312,378
2,563 Added 3.53%
75,221 $8.3 Million
Q1 2020

May 06, 2020
BUY
$87.74 - $152.74 $618,654 - $1.08 Million
7,051 Added 10.75%
72,658 $7.25 Million
Q4 2019

Feb 05, 2020
BUY
$117.65 - $153.73 $181,063 - $236,590
1,539 Added 2.4%
65,607 $9.79 Million
Q3 2019

Oct 23, 2019
BUY
$125.18 - $143.24 $2,128 - $2,435
17 Added 0.03%
64,068 $8.21 Million
Q2 2019

Aug 14, 2019
BUY
$125.55 - $144.48 $815,949 - $938,975
6,499 Added 11.29%
64,051 $9.13 Million
Q1 2019

May 01, 2019
BUY
$121.81 - $142.95 $5,968 - $7,004
49 Added 0.09%
57,552 $8.23 Million
Q4 2018

Jan 31, 2019
SELL
$115.94 - $166.74 $320,342 - $460,702
-2,763 Reduced 4.58%
57,503 $7.13 Million
Q3 2018

Nov 07, 2018
SELL
$161.01 - $180.57 $181,297 - $203,321
-1,126 Reduced 1.83%
60,266 $10.1 Million
Q2 2018

Aug 06, 2018
BUY
$146.33 - $183.18 $8.98 Million - $11.2 Million
61,392 New
61,392 $10.6 Million

Others Institutions Holding JAZZ

# of Institutions
562
Shares Held
62.7M
Call Options Held
563K
Put Options Held
77.8K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.64B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email